Heights Capital Management, Inc Cabaletta Bio, Inc. Transaction History
Heights Capital Management, Inc
- $375 Billion
- Q2 2025
A detailed history of Heights Capital Management, Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Heights Capital Management, Inc holds 3,144,106 shares of CABA stock, worth $5.22 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
3,144,106Holding current value
$5.22 Million% of portfolio
1.28%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
94Shares Held
77.1MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$16.1 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$14.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$11.3 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$9.99 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$8.3 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $48.2M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...